Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple Dose Oxytocin in High/Low Anxiety Males
NCT03085654Phase 1Completed
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Mar 2017
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in anxiety disorder (6 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Changes between acute and chronic administration of oxytocin on amygdala activity at 5 days and Changes between acute and chronic administration of oxytocin on amygdala connectivity at 5 days. Started Mar 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT03085654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03085654.